Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Breast 1

Conditions

Sarcoma 4Sarcoma, Ewing 3Osteosarcoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Liposarcoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Leiomyosarcoma 1Hemangiosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colonic Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 4pembrolizumab 3Irinotecan 3Carboplatin 3Specimen Handling 2Radiosurgery 2Psychiatric Rehabilitation 2Observation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Floxuridine 2Erlotinib Hydrochloride 2Cyclophosphamide 2Cetuximab 2Bortezomib 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1spartalizumab 1sodium thiosulfate 1selpercatinib 1rucaparib 1repotrectinib 1pidilizumab 1pazopanib 1p53 peptide 264-272, human 1motexafin lutetium 1montanide ISA 51 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × abemaciclib × Sarcoma × Clear all
NCT02784795 2025-08-21

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Eli Lilly and Company

Phase 1 Terminated
94 enrolled 28 charts
BreastGastrointestinalSarcoma

Breast Neoplasms, Colonic Neoplasms, Sarcoma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡